176 related articles for article (PubMed ID: 34140854)
1. Cost-effective purification process development for chimeric hepatitis B core (HBc) virus-like particles assisted by molecular dynamic simulation.
Zhang B; Yin S; Wang Y; Su Z; Bi J
Eng Life Sci; 2021 Jun; 21(6):438-452. PubMed ID: 34140854
[TBL] [Abstract][Full Text] [Related]
2. In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process.
Zhang Y; Liu Y; Zhang B; Yin S; Li X; Zhao D; Wang W; Bi J; Su Z
Protein Expr Purif; 2021 Feb; 178():105747. PubMed ID: 32898688
[TBL] [Abstract][Full Text] [Related]
3. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them.
Sani MZ; Bargahi A; Momenzadeh N; Dehghani P; Moghadam MV; Maleki SJ; Nabipour I; Shirkani A; Akhtari J; Hesamizadeh K; Heidari S; Omrani F; Akbarzadeh S; Mohammadi M
Appl Microbiol Biotechnol; 2021 Jan; 105(1):77-91. PubMed ID: 33215260
[TBL] [Abstract][Full Text] [Related]
5. Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.
Sominskaya I; Skrastina D; Dislers A; Vasiljev D; Mihailova M; Ose V; Dreilina D; Pumpens P
Clin Vaccine Immunol; 2010 Jun; 17(6):1027-33. PubMed ID: 20410327
[TBL] [Abstract][Full Text] [Related]
6. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
7. Experimental and molecular dynamics simulation studies on the physical properties of three HBc-VLP derivatives as nanoparticle protein vaccine candidates.
Luo H; Ma Y; Bi J; Li Z; Wang Y; Su Z; Gerstweiler L; Ren Y; Zhang S
Vaccine; 2024 May; ():. PubMed ID: 38811268
[TBL] [Abstract][Full Text] [Related]
8. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
Liu D; Li B; Bi C; Qiao H; Wu X
Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
Czarnota A; Tyborowska J; Peszyńska-Sularz G; Gromadzka B; Bieńkowska-Szewczyk K; Grzyb K
Microb Cell Fact; 2016 Apr; 15():62. PubMed ID: 27075377
[TBL] [Abstract][Full Text] [Related]
12. Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).
Mihailova M; Boos M; Petrovskis I; Ose V; Skrastina D; Fiedler M; Sominskaya I; Ross S; Pumpens P; Roggendorf M; Viazov S
Vaccine; 2006 May; 24(20):4369-77. PubMed ID: 16574285
[TBL] [Abstract][Full Text] [Related]
13. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
Yin Y; Zhang J; Dong D; Liu S; Guo Q; Song X; Li G; Fu L; Xu J; Chen W
Vaccine; 2008 Oct; 26(46):5814-21. PubMed ID: 18786589
[TBL] [Abstract][Full Text] [Related]
14. Chimeric hepatitis B virus core particles displaying Neisserial surface protein A confer protection against virulent
Hou Y; Yan T; Cao H; Liu P; Zheng K; Li Z; Deng Q; Hu S
Int J Nanomedicine; 2019; 14():6601-6613. PubMed ID: 31496701
[TBL] [Abstract][Full Text] [Related]
15. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
Strods A; Ose V; Bogans J; Cielens I; Kalnins G; Radovica I; Kazaks A; Pumpens P; Renhofa R
Sci Rep; 2015 Jun; 5():11639. PubMed ID: 26113394
[TBL] [Abstract][Full Text] [Related]
16. Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.
Kazaks A; Lu IN; Farinelle S; Ramirez A; Crescente V; Blaha B; Ogonah O; Mukhopadhyay T; de Obanos MP; Krimer A; Akopjana I; Bogans J; Ose V; Kirsteina A; Kazaka T; Stonehouse NJ; Rowlands DJ; Muller CP; Tars K; Rosenberg WM
BMC Biotechnol; 2017 Nov; 17(1):79. PubMed ID: 29126399
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris.
Freivalds J; Dislers A; Ose V; Pumpens P; Tars K; Kazaks A
Protein Expr Purif; 2011 Feb; 75(2):218-24. PubMed ID: 20854910
[TBL] [Abstract][Full Text] [Related]
18. Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development.
Zhao Y; Li Z; Voyer J; Li Y; Chen X
ACS Appl Mater Interfaces; 2022 May; 14(19):21872-21885. PubMed ID: 35467839
[TBL] [Abstract][Full Text] [Related]
19. Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core.
Rybka JD; Mieloch AA; Plis A; Pyrski M; Pniewski T; Giersig M
Nanomaterials (Basel); 2019 Jan; 9(2):. PubMed ID: 30691173
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and Vaccine Efficacy Boosted by Engineering Human Heavy Chain Ferritin and Chimeric Hepatitis B Virus Core Nanoparticles.
Qu Y; Zhang B; Wang Y; Yin S; Sun Y; Middelberg A; Bi J
ACS Appl Bio Mater; 2021 Sep; 4(9):7147-7156. PubMed ID: 35006946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]